English – Page 326 – TechStock²

Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. (NASDAQ: FOLD) is no longer trading like a “typical biotech story stock.” After BioMarin’s all-cash $14.50-per-share takeover agreement, FOLD has effectively become a deal-driven, merger-arbitrage name—meaning next week’s action is likely

22 December 2025

Biotech Stocks·Investment News·Mergers and Acquisitions·Pharmaceutical Industry·Stock Market Analysis

Biogen Stock Forecast for the Week Ahead (Dec. 22–26, 2025): BIIB Near 52-Week High as Leqembi Momentum Meets an Analyst Split

Biogen Inc. (NASDAQ: BIIB) heads into the Christmas week with its stock hovering just below a recent high, a fresh spike in trading volume, and a narrative that’s increasingly dominated by one question: can the company turn Leqembi’s momentum into

21 December 2025

Biotech Stocks·Financial Forecasts·Investment Analysis·Stock Market

Uber (UBER) Stock Week Ahead: FTC Uber One Lawsuit Overhang Meets Robotaxi Momentum and Diverging Analyst Targets

Published: December 21, 2025 — Uber Technologies, Inc. (NYSE: UBER) heads into a holiday-shortened trading week with its stock hovering near the psychologically important $80 level, after a volatile December that has forced investors to weigh two powerful (and competing)

21 December 2025

Autonomous Vehicles·Investment Analysis·Legal Updates·Stock Market·Uber News

Hecla Mining (HL) Stock Week Ahead: S&P MidCap 400 Inclusion, Silver at Record Highs, and Key Levels to Watch (Dec. 22–26, 2025)

Dec. 21, 2025 (Week-Ahead Outlook) — Hecla Mining Company (NYSE: HL) heads into the Christmas week spotlighted by a rare mix of momentum and event risk: a scheduled addition to the S&P MidCap 400 Index on Monday, Dec. 22, a

21 December 2025

Financial News·Investment Strategies·Market Analysis·Silver Prices·Stock Market

Procter & Gamble Stock (NYSE: PG) Week-Ahead Outlook: Analyst Calls, Holiday Trading, and What Could Move Shares Dec. 22–26, 2025

As of Sunday, December 21, 2025, Procter & Gamble (P&G) stock is heading into a holiday-shortened trading week with a familiar mix of defensive appeal, brand-driven innovation headlines, and renewed Wall Street debate about what “steady” should look like in

21 December 2025

Analyst Insights·Holiday Trading·Investing·Procter & Gamble·Stock Market

Newmont (NEM) Stock Week Ahead: Dividend Day, Gold Price Tailwinds, and Key Catalysts for Dec. 22–26, 2025

Newmont Corporation (NYSE: NEM) heads into the Christmas-shortened trading week near a fresh high as precious-metals momentum remains the dominant driver of sentiment. Shares closed at $101.29 on Friday, Dec. 19, putting the stock within about 1% of its recent

21 December 2025

Dividends·Financial News·Gold·Investment Strategies·Stock Market

Philip Morris International (PM) Stock Week Ahead: Dividend Watch, FDA Nicotine Pouch Developments, Analyst Targets and Key Catalysts for Dec. 22–26, 2025

Published: Sunday, Dec. 21, 2025 (week-ahead outlook) Philip Morris International Inc. (NYSE: PM) heads into the Christmas-shortened trading week with a familiar mix of forces: a defensive consumer-staples profile, an income-driven shareholder base watching the next dividend milestone, and an

21 December 2025

Dividends·FDA Updates·Investment Analysis·Market Trends·Stocks

American Express Stock (AXP) Week Ahead: Dividend Update, Analyst Price Targets, Credit Trends and Key Catalysts for Christmas Week

American Express (NYSE: AXP) heads into Christmas week with shares hovering near record territory after a strong 2025 run and a busy mid-December news cycle that included fresh analyst target hikes, a dividend declaration, and updated credit performance data. With

21 December 2025

Analyst Insights·Dividend Updates·Stock Analysis

Gilead Sciences (GILD) Stock Week-Ahead Outlook: Pricing Deal Shockwave, HIV Pipeline Momentum, and Key Catalysts for Dec 22–26, 2025

December 21, 2025 — Gilead Sciences, Inc. (NASDAQ: GILD) heads into a holiday-shortened trading week with an unusually dense mix of policy headlines and pipeline momentum—two forces that can quickly reprice a large-cap biopharma stock even when overall market volume

21 December 2025

Investment Strategies·Market Forecasts·Pharma Industry·Stock Analysis

Intuit (INTU) Stock Week Ahead: Stablecoin Partnership With Circle, TurboTax Push, and What Investors Are Watching (Dec. 22–26, 2025)

Intuit Inc. (NASDAQ: INTU) heads into a holiday-shortened trading week with a familiar narrative—strong recurring software demand and an aggressive push into AI—plus a newer, headline-grabbing theme: stablecoins. As of the latest available pricing going into the week of Monday,

21 December 2025

Cryptocurrency·Financial News·Fintech·Investments·Stock Market

Caterpillar Stock (CAT) Week-Ahead Outlook: AI Data-Center Demand Meets Holiday-Week Volatility, Tariffs, and New Deal Headlines

As of Sunday, December 21, 2025, Caterpillar Inc. (NYSE: CAT) heads into a holiday-shortened trading week after a sharp pullback that tested the market’s newest narrative: that “AI isn’t just chips”—it’s also generators, turbines, and the heavy equipment needed to

21 December 2025

Artificial Intelligence·Economic News·Investing·Market Analysis·Stock Market

Adobe Stock Week Ahead: ADBE Faces Fresh AI-Lawsuit Risk After Upbeat FY2026 Outlook — What Investors Watch Dec 22–26, 2025

Adobe Inc. (NASDAQ: ADBE) heads into a holiday-shortened trading week with investors balancing two competing narratives: steady subscription-driven fundamentals (and a higher-looking FY2026 outlook) versus rising legal and competitive risk tied to generative AI. Adobe stock last closed around $355.86,

21 December 2025

Investor Insights·Market Trends